Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography
Publication Date: March 1, 2018
Last Updated: March 14, 2022
Recommendations
Current FDA Labeling of UEA Use
The only FDA-approved use for UEAs in cardiovascular disease is for LVO. However, given significant scientific literature support, other off-label uses of UEAs (such as MP, pediatric and vascular applications, and use during stress echocardiography) are recommended in the present document according to the 2015 clinical practice guidelines. (, )
The approved indications for use of ultrasound enhancing agents are governed by each country and societal endorsement of this document does not imply otherwise.
706
Title
Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography
Authoring Organization
American Society of Echocardiography